William Reardon - Tekla World Independent Trustee

Mr. William S. Reardon, CPA serves as an Independent Trustee of the Tekla World Healthcare Fund. Mr. Reardons personal experience as a Life Science audit partner at PricewaterhouseCoopers LLP, with a broad spectrum of companies across the corporate life cycle from startup to successful product driven pharmaceutical companies, provides each Fund with a valuable perspective in analyzing life science company opportunities and in valuing the venture portion of the portfolio. Until 2002, Mr. Reardon was a business assurance partner in PwCs Boston office and leader of the Life Sciences Industry Practice for New England and the Eastern U.S., working closely with many of the Firms public clients in SECregistered equity, convertible and RD limited partnership offerings and many initial public offerings. He serves on the Valuation and Audit Committees of each Fund. From 19982000 he served on the Board of the Emerging Companies Section of the Biotechnology Industry Organization and from 2000 to 2002 he served on the Board of Directors of the Massachusetts Biotechnology Council . During his professional career, he was a frequent speaker at BIO conferences and MBC Industry meetings on issues affecting biotechnology companies. He currently also serves as a board member and audit committee chair of two developmentstage public companies, Synta Pharmaceuticals and Idera Pharmaceuticals